Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Sodium Chloride × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Melanoma 5 Skin Neoplasms 3 Breast Neoplasms 2 Recurrence 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Hodgkin Disease 1 Gastrointestinal Neoplasms 1 Ectropion 1 Colorectal Neoplasms 1 Cicatrix 1 Brain Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 17 fludarabine phosphate 15 Cyclophosphamide 14 Mycophenolic Acid 13 Cyclosporine 13 Whole-Body Irradiation 12 Tacrolimus 8 Radiotherapy 8 Methotrexate 7 Melphalan 7 Busulfan 7 pembrolizumab 6 Antilymphocyte Serum 6 Nivolumab 5 Methylprednisolone 5 Filgrastim 5 Etoposide 5 Sirolimus 4 Therapeutics 3 Polymerase Chain Reaction 3 Cord Blood Stem Cell Transplantation 3 sargramostim 2 merphos 2 bempegaldesleukin 2 Vitamin B 12 2 Transplantation 2 Surgical Procedures, Operative 2 Prednisone 2 Oxaliplatin 2 Ondansetron 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05899465 2025-03-18

PRIME

University of Aarhus

Phase 3 Recruiting

Melanoma, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡